COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics SA publiera ses résultats du premier semestre 2019 le 30 août 2019
22/08/2019
Communiqué de presse Gosselies, Belgique, le 22 août 2019, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies cellulaires [...]
Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan
22/08/2019
Company Announcement DARZALEX ® approved in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplant in [...]
IBA Reports Half Year Results for 2019
22/08/2019
Group revenue up 13.8% to EUR 102.8 million, with higher revenues expected over H2 2019 Market leadership confirmed in all business lines and major geographies Two Proteus ® ONE solutions sold in Italy and USA Contract [...]
IBA annonce ses résultats du premier semestre 2019
22/08/2019
Hausse des revenus du groupe à hauteur de 13,8% pour atteindre EUR 102,8 millions, avec des revenus supérieurs attendus au second semestre 2019 Position de leader confirmée sur le marché, tous secteurs d’activité [...]
Interim Report Q2 2019: Strong performance across the group with 16% organic revenue growth in Q2. Guidance upgraded for GN Audio
22/08/2019
GN delivered 16% organic revenue growth in Q2 2019. Revenue growth was 19% including around 3% impact from the development in foreign exchange rates EBITA increased 16% compared to Q2 2018 driven by strong operational [...]
Devonian Announces the Closing of a $315,000 Private Placement and an Additional Loan of $500,000
22/08/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) (TSXV: GSD) is [...]
Devonian complète un placement privé de 315 000 $ et obtient un prêt additionnel de 500 000 $
22/08/2019
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 21 août 2019 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSXV: GSD) a le plaisir d’annoncer qu’ [...]
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock
22/08/2019
REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pricing of an underwritten [...]
Ambu A/S: Ambu invests into a 100% direct sales organisation for pulmonology in the US
22/08/2019
Ambu has decided to invest further and strengthen its largest market by transitioning sales of aScope™ products from the US distributor. As a result, Ambu will move to a 100% direct sales organisation for pulmonary [...]
Genmab Announces Preliminary Data to be Presented at IASLC 2019 World Conference on Lung Cancer
21/08/2019
Media Release Copenhagen, Denmark, August 21, 2019 Genmab A/S (Nasdaq: GMAB) announced today that preliminary data from the Phase I/II trial of enapotamab vedotin in advanced non-small cell lung cancer (NSCLC) has been [...]
Golden Leaf Holdings Removed from Defaulting Issuer List
21/08/2019
TORONTO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis company built around recognized brands for the wellness and recreational markets [...]
Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq
21/08/2019
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) announced that, further to its press release dated August 12, [...]
Helix BioPharma Corp. Closes $7.0 Million Private Placement
21/08/2019
RICHMOND HILL, Ontario, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Exactus Inc. Announces CEO Search – Interim Appointments
21/08/2019
DELRAY BEACH, Fla., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI) a healthcare company pursuing opportunities in hemp derived cannabidiol (CBD) products, today announced that Bobby Yampolsky, founder of [...]
Micron Solutions, Inc. Announces Compliance Plan Acceptance Letter from NYSE American
21/08/2019
FITCHBURG, Ma., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
BeiGene Announces U.S. FDA Acceptance and Grant of Priority Review for its New Drug Application of Zanubrutinib in Patients with Relapsed/Refractory Mantle Cell Lymphoma
21/08/2019
CAMBRIDGE, Mass. and BEIJING, China, Aug. 21, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Kane Biotech Announces Second Quarter 2019 Financial Results
21/08/2019
WINNIPEG, Manitoba, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Avinger Announces Proposed Underwritten Public Offering of Common Stock
21/08/2019
REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that it intends to offer shares of [...]
Roxadustat Approved in China for Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
21/08/2019
SAN FRANCISCO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) today announced that the National Medical Products Administration (NMPA) in China has approved expansion of the marketing authorization of [...]

Pages